What's behind the FDA flip on Moderna's flu shot? #health

From refusal to reconsideration: what changed Regulatory tensions over Moderna’s experimental mRNA influenza vaccine played out publicly when the U.S. Food and Drug Administration initially declined to accept the company’s application for review, then reversed course and told Moderna it would...